DENMEAD, England--(BUSINESS WIRE)--Microsulis Medical Limited (MML) has announced the appointment of Bill McMullen as Clinical Director to work with clinicians worldwide on clinical trials and analysis relating to the Acculis pMTA system for tumour ablation to document this revolutionary new technology in clinical practice, focusing on data relating to the effectiveness and performance of the system in liver and lung tumours. This will build on the established existing clinical data that has emerged from the development trials and the ongoing international audit of clinical use.
